(Q45157683)

10 December 2017

title

Elevated circulating levels of thioredoxin and stress in chronic heart failure (English)

1 reference

10 December 2017

1 reference

chronic heart failure

1 reference

5

1 reference

10 December 2017

Andreas Jekell

1

1 reference

10 December 2017

Akter Hossain

series ordinal

2

1 reference

10 December 2017

Urban Alehagen

series ordinal

3

1 reference

10 December 2017

Ulf Dahlström

series ordinal

4

1 reference

10 December 2017

publication date

1 December 2004

1 reference

European Journal of Heart Failure

10 December 2017

published in

1 reference

10 December 2017

volume

6

1 reference

10 December 2017

issue

7

1 reference

10 December 2017

page(s)

883-890

1 reference

Pathophysiology of chronic heart failure

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Oxidants, oxidative stress and the biology of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Neuroendocrine regulation of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Reactive oxygen species, antioxidants, and the mammalian thioredoxin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Secretion of 10-kDa and 12-kDa thioredoxin species from blood monocytes and transformed leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

The importance of selenium to human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Heart failure clinics: organization, development, and experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Psychoneuroimmunology: interactions between the nervous system and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Psychological, cardiovascular, and metabolic correlates of individual differences in cortisol stress recovery in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Monoclonal antibodies to human thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Oxy free radical system in heart failure and therapeutic role of oral vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Enzyme-linked immunospot assay for detection of thioredoxin and thioredoxin reductase secretion from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Cytokine profile in chronic cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Elevated Levels of 8-iso-Prostaglandin F 2α in Pericardial Fluid of Patients With Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

Circulating Interleukin-6 in Severe Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.003

10.1016/J.EJHEART.2004.03.003

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference